Drug Profile
Atazanavir/ritonavir - Emcure Pharmaceuticals
Alternative Names: Ritonavir/atazanavir - Emcure PharmaceuticalsLatest Information Update: 21 Sep 2021
Price :
$50
*
At a glance
- Originator Emcure Pharmaceuticals
- Class Amides; Antiretrovirals; Carbamates; Oligopeptides; Pyridines; Small molecules; Thiazoles
- Mechanism of Action HIV protease inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Registered HIV-1 infections
Most Recent Events
- 28 Nov 2018 Atazanavir/ritonavir is not yet available in USA for the treatment of HIV-1 infections (Emcure website, November 2018)